Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Retained Earnings (2018 - 2025)

TransMedics has reported Retained Earnings over the past 8 years, most recently at $124000.0 for Q4 2025.

  • Quarterly results put Retained Earnings at $124000.0 for Q4 2025, up 100.03% from a year ago — trailing twelve months through Dec 2025 was $124000.0 (up 100.03% YoY), and the annual figure for FY2025 was $124000.0, up 100.03%.
  • Retained Earnings for Q4 2025 was $124000.0 at TransMedics, up from $101000.0 in the prior quarter.
  • Over the last five years, Retained Earnings for TMDX hit a ceiling of $124000.0 in Q4 2025 and a floor of -$507.7 million in Q3 2023.
  • Median Retained Earnings over the past 5 years was -$412.2 million (2021), compared with a mean of -$274.0 million.
  • Biggest five-year swings in Retained Earnings: crashed 465632.63% in 2021 and later surged 143.35% in 2025.
  • TransMedics' Retained Earnings stood at -$442.4 million in 2021, then decreased by 8.19% to -$478.7 million in 2022, then dropped by 5.23% to -$503.7 million in 2023, then increased by 7.04% to -$468.2 million in 2024, then skyrocketed by 100.03% to $124000.0 in 2025.
  • The last three reported values for Retained Earnings were $124000.0 (Q4 2025), $101000.0 (Q3 2025), and -$407.7 million (Q2 2025) per Business Quant data.